- Oncology
- Inflammatory Bowel Disease
- Oncology Supportive Care (Mucositis)
- Dermatology
- Histology and Molecular Services
More Information
For a direct and rapid response on all our products, assays and services click here
Alternatively email info@epistem.co.uk
Or call our Business Development Team on +44 (0) 161 606 7258.
Plucked Hair Immunohistochemistry
Plucked Hair Labelling Epistem has developed an innovative, non-invasive plucked hair biomarker platform that measures target changes (pharmacodynamic response), including phosphorylated proteins, within a single plucked human hair. Hairs are ideal surrogates for the measurement of direct response to drug treatment for biomarker studies. Highly sensitive to therapeutic agents, hairs respond to drug treatment within hours of exposure. Collection is also minimally invasive, with few ethical issues, permitting repeat sampling from subjects over the duration of a clinical study. | ![]() Image: Transverse section of a single plucked human hair ( H&E) |
Hairs are collected, fixed and then shipped to Epistem for processing. For proof of concept studies, Epistem can arrange for hair collection on behalf of the Sponsor. Hairs are then either wax embedded and sectioned, or processed as whole mounts. For each antigen, antibody labelling protocols are optimised, with inter- and intra- donor variability and antigen stability post-collection determined. Epistem's scientists will advise on the suitability of labelling whole mount hairs versus longitudinal sections, depending on antigen location. | ![]() Image: Ki67 labelled whole mount human hair |
Imaging
Manual or image analysis techniques are used to quantify labelling and provide an objective readout. Labelling intensity, percentage of labelled cells and distribution of labelling are determined. Confocal scanning microscopy is used to quantify the label within whole mounts.
GenetRxTM
For information on Epistem's complimentary mRNA expression analysis for single plucked hair follicles click here.
Additional Biomarker Platforms
Epistem is also developing other biomarker platforms including:
- ex vivo maintenance, treatment and labelling of plucked human hairs for detection of direct responses to drug exposure.
- Immunohistochemistry and qRT-PCR from skin biopsies and tumour derived samples.
















.jpg)
.jpg)